Laboratoire de Neurogastroentérologie et Motricité Digestive, Service de Gastroentérologie, Hôpital Saint-Luc, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montréal, QC, Canada H2X 3J4.
Can J Gastroenterol Hepatol. 2016;2016:7424831. doi: 10.1155/2016/7424831. Epub 2016 Apr 3.
Background. Patients with chronic pancreatitis (CP) exhibit numerous risk factors for the development of small intestinal bacterial overgrowth (SIBO). Objective. To determine the prevalence of SIBO in patients with CP. Methods. Prospective, single-centre case-control study conducted between January and September 2013. Inclusion criteria were age 18 to 75 years and clinical and radiological diagnosis of CP. Exclusion criteria included history of gastric, pancreatic, or intestinal surgery or significant clinical gastroparesis. SIBO was detected using a standard lactulose breath test (LBT). A healthy control group also underwent LBT. Results. Thirty-one patients and 40 controls were included. The patient group was significantly older (53.8 versus 38.7 years; P < 0.01). The proportion of positive LBTs was significantly higher in CP patients (38.7 versus 2.5%: P < 0.01). A trend toward a higher proportion of positive LBTs in women compared with men was observed (66.6 versus 27.3%; P = 0.056). The subgroups with positive and negative LBTs were comparable in demographic and clinical characteristics, use of opiates, pancreatic enzymes replacement therapy (PERT), and severity of symptoms. Conclusion. The prevalence of SIBO detected using LBT was high among patients with CP. There was no association between clinical features and the risk for SIBO.
患有慢性胰腺炎(CP)的患者存在许多发生小肠细菌过度生长(SIBO)的风险因素。目的:确定 CP 患者中 SIBO 的患病率。方法:2013 年 1 月至 9 月进行的前瞻性、单中心病例对照研究。纳入标准为年龄 18 至 75 岁,具有 CP 的临床和影像学诊断。排除标准包括胃、胰腺或肠道手术史或明显的临床胃轻瘫。使用标准乳果糖呼气试验(LBT)检测 SIBO。健康对照组也进行了 LBT。结果:纳入了 31 例患者和 40 例对照组。患者组年龄明显更大(53.8 岁比 38.7 岁;P < 0.01)。CP 患者的 LBT 阳性率明显更高(38.7%比 2.5%:P < 0.01)。与男性相比,女性 LBT 阳性率呈升高趋势(66.6%比 27.3%;P = 0.056)。LBT 阳性和阴性亚组在人口统计学和临床特征、阿片类药物使用、胰酶替代治疗(PERT)和症状严重程度方面无差异。结论:LBT 检测到 CP 患者中 SIBO 的患病率较高。临床特征与 SIBO 风险之间无关联。